Asabys Partners logo

Asabys Partners

Europe, Catalonia, Spain, Barcelona

Description

Asabys Partners is based in Barcelona and specialises in early-stage biotech, medical technology and healthcare innovation projects.

Investor Profile

Asabys Partners has made 29 investments, with 6 in the past 12 months and 55% as lead.

Stage Focus

  • Series A (41%)
  • Seed (17%)
  • Series B (17%)
  • Series Unknown (14%)
  • Series C (3%)
  • Convertible Note (3%)
  • Series D (3%)

Country Focus

  • Spain (62%)
  • Belgium (17%)
  • Germany (7%)
  • Iceland (7%)
  • United States (3%)
  • France (3%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical Device
  • Medical
  • Life Science
  • Pharmaceutical
  • Therapeutics
  • Health Diagnostics
  • Consumer Electronics
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Asabys Partners frequently co-invest with?

Wellington Partners
Europe, Bayern, Germany, Munich
Co-Investments: 3
AdBio partners
Europe, Ile-de-France, France, Paris
Co-Investments: 4
BStartup
Europe, Catalonia, Spain, Sant Cugat Del Vallès
Co-Investments: 2
Criteria Venture Tech
Europe, Catalonia, Spain, Barcelona
Co-Investments: 4
Ysios Capital
Europe, Pais Vasco, Spain, San Sebastian
Co-Investments: 4
Alta Life Sciences
Europe, Catalonia, Spain, Barcelona
Co-Investments: 3
Andera Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 2
ICF Capital
Europe, Catalonia, Spain, Barcelona
Co-Investments: 2
Sofinnova Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 2
Co-Investments: 7

Which angels does Asabys Partners often collaborate with?

JM
North America, Massachusetts, United States, Cambridge
Shared Deals: 1

What are some of recent deals done by Asabys Partners?

Augustine Therapeutics

Leuven, Vlaams-Brabant, Belgium

Augustine Therapeutics is discovering and developing innovative medicines for the treatment of neuromuscular and neurodegeneratives diseases

BiopharmaBiotechnologyPharmaceutical
Series AMar 24, 2025
Amount Raised: $84,139,626
Quibim

Valencia, Comunidad Valenciana, Spain

Quibim is a radiomics company specializing in quantitative imaging of biomarkers and medical applications in precision medicine.

Artificial Intelligence (AI)BiotechnologyClinical TrialsHealth CareHealth Diagnostics
Series AJan 28, 2025
Amount Raised: $50,000,000
INBRAIN Neuroelectronics

Barcelona, Catalonia, Spain

INBRAIN Neuroelectronics is a BCI therapeutics company using graphene to build the least invasive and most intelligent neural platform

Artificial Intelligence (AI)BiotechnologyConsumer ElectronicsHealth CareMedical DeviceNanotechnologySemiconductorTherapeutics
Series BOct 29, 2024
Amount Raised: $49,771,699
AgomAb Therapeutics

Antwerpen, Antwerpen, Belgium

Agomab is a biotechnology company developing therapies that maintains and restores organ function in diseases characterized by fibrosis.

BiotechnologyHealth CareTherapeutics
Series DOct 25, 2024
Amount Raised: $88,672,973
Medlumics

Madrid, Madrid, Spain

Medlumics is a startup employing biophotonic technologies to develop products that improve human living standards.

BiotechnologyCRMHealth CareHospitalInformation TechnologyMedical DeviceRobotics
Series UnknownJul 29, 2024
Augustine Therapeutics

Leuven, Vlaams-Brabant, Belgium

Augustine Therapeutics is discovering and developing innovative medicines for the treatment of neuromuscular and neurodegeneratives diseases

BiopharmaBiotechnologyPharmaceutical
Series AJun 26, 2024
Amount Raised: $18,206,938
XRHealth

Needham, Massachusetts, United States

XRHealth is a telemedicine company that uses virtual reality and augmented reality solutions for healthcare applications.

Augmented RealityHealth CareVirtual RealityWellness
Series UnknownJan 9, 2024
Amount Raised: $6,000,000
AgomAb Therapeutics

Ghent, Oost-Vlaanderen, Belgium

AgomAb Therapeutics is a Company is developing growth factor-mimetic agonistic monoclonal antibodies to regenerate damaged tissues.

BiotechnologyHealth CareTherapeutics
Series COct 11, 2023
Amount Raised: $100,817,696
Gradient Denervation Technologies

Paris, Ile-de-France, France

Gradient Denervation Technologies develops a medical device for a transvascular treatment of pulmonary hypertension.

BiotechnologyMedical Device
Series ASep 7, 2023
Amount Raised: $14,977,539
Orikine Bio

Barcelona, Catalonia, Spain

Orikine Bio is a pioneer biotech company in the field of tailored cytokines for the treatment of immune-mediated disorders.

BiotechnologyMedicalProduct Research
SeedJul 18, 2023
Amount Raised: $6,175,633